Regencell Bioscience Holdings Total Liabilities

Regencell Bioscience Holdings (RGC) currently reports a total liabilities of $1.8M as of December 2025. That compares with $760K in the prior-year period — up 134.9% year over year. Use the charts on this page to explore Regencell Bioscience Holdings's total liabilities history and peer comparisons.

Regencell Bioscience Holdings's total liabilities increased from $760K to $1.8M — a 134.9% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Regencell Bioscience Holdings reported $1.8M in total liabilities as of December 2025. That compares with $760K in the prior-year period — up 134.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $1.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Regencell Bioscience Holdings, and consider following RGC for alerts when major investors trade the stock.

Regencell Bioscience Holdings is classified in the Healthcare sector. On total liabilities, it currently shows $1.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RGC with unrelated industries.